Cargando…

Does the Fc Region Have a Role in the Ocular Half-life After Intravitreal Injection?

Detalles Bibliográficos
Autores principales:	Caruso, Antonello, Mazer, Norman A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Association for Research in Vision and Ophthalmology 2020
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405609/ https://www.ncbi.nlm.nih.gov/pubmed/32407522 http://dx.doi.org/10.1167/iovs.61.5.20

Ejemplares similares

Author Response: Does the Fc Region Have a Role in the Ocular Half-Life After Intravitreal Injection?
por: Joo, Kwangsic, et al.
Publicado: (2020)

Are Ocular and Serum Half-Lives After Ranibizumab Intravitreal Injection Dependent on Dose?
por: van Donge, Tamara, et al.
Publicado: (2023)

Understanding the Half-Life Extension of Intravitreally Administered Antibodies Binding to Ocular Albumin
por: Hauri, Simon, et al.
Publicado: (2020)

Active Transport and Ocular Distribution of Intravitreally Injected Liposomes
por: Eriksen, Anne Zebitz, et al.
Publicado: (2023)

Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-life
por: Mackness, Brian C., et al.
Publicado: (2019)

Effects of Intravitreal Injection on Ocular Surface and Anterior Segment Parameters
por: Ulutas, Hafize Gokben, et al.
Publicado: (2021)

Immediate sequential bilateral intravitreal injections: an Indian perspective
por: Tripathy, Koushik
Publicado: (2017)

Human FcRn Tissue Expression Profile and Half-Life in PBMCs
por: Fan, Yao-Yun, et al.
Publicado: (2019)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
por: Pandey, Neeraj, et al.
Publicado: (2013)

Correspondence
por: Caruso, Antonello, et al.
Publicado: (2020)

Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone
por: Kocabora, M Selim, et al.
Publicado: (2008)

Ocular pathogenesis and immune reaction after intravitreal dispase injection in mice
por: Tan, Juan, et al.
Publicado: (2012)

Ocular and Systemic Results of Intravitreal Bevacizumab Injection in Retinopathy of Prematurity Treatment
por: Cevik, Sadik Gorkem, et al.
Publicado: (2020)

Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII)
por: Wang, Rui, et al.
Publicado: (2022)

Paralytic ileus after bilateral intravitreal injection of bevacizumab
por: Kim, Young Gyun, et al.
Publicado: (2016)

Unimanual upper and lower eyelid retraction for intravitreal injections
por: Dudani, Ajay I, et al.
Publicado: (2021)

Ocular biodistribution of bevasiranib following a single intravitreal injection to rabbit eyes
por: Dejneka, Nadine S., et al.
Publicado: (2008)

Ocular kinetics and safety of intravitreally injected angiotensin converting enzyme inhibitor lisinopril
por: Nath, Madhu, et al.
Publicado: (2018)

Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice
por: Braster, Rens, et al.
Publicado: (2017)

Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension
por: Cao, Kejia, et al.
Publicado: (2020)

Ocular complications following intravitreal bevacizumab injection for retinopathy of prematurity and assessment of risk factors
por: Bazvand, Fatemeh, et al.
Publicado: (2021)

Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life
por: Gjølberg, Torleif Tollefsrud, et al.
Publicado: (2022)

Rothia dentocariosa endophthalmitis following intravitreal injection—a case report
por: Hayes, R. A., et al.
Publicado: (2017)

A surprising intravitreal injection attempt: Ozurdex™ implantation for Behçet's disease
por: Furundaoturan, Onur, et al.
Publicado: (2020)

Incidence of ocular hypertension after intravitreal injection of anti-VEGF agents in the treatment of neovascular AMD
por: Moraru, Andreea, et al.
Publicado: (2017)

Multiple Intravitreal Ranibizumab Injections for Persistant Choroidal Neovascularization Associated with Presumed Ocular Histoplasmosis Syndrome
por: Yılmaz, Turgut, et al.
Publicado: (2017)

Ocular safety of repeated intravitreal injections of Carboplatin and Digoxin: A preclinical study on the healthy rabbits
por: Khodabande, Alireza, et al.
Publicado: (2021)

Intravitreal injection technique
por: Yorston, David
Publicado: (2014)

THE SUCCESS OF INTRAVITREAL INJECTIONS
por: O’Donnell, Matthew, et al.
Publicado: (2017)

Intravitreal Injection Technique
por: Rezaei, Kasra A., et al.
Publicado: (2016)

Advances in Therapeutic Fc Engineering – Modulation of IgG-Associated Effector Functions and Serum Half-life
por: Saxena, Abhishek, et al.
Publicado: (2016)

Increased half-life and enhanced potency of Fc-modified human PCSK9 monoclonal antibodies in primates
por: Shen, Yijun, et al.
Publicado: (2017)

Non-arteritic ischemic optic neuropathy followed by intravitreal bevacizumab injection: Is there an association?
por: Bodla, Ali A, et al.
Publicado: (2010)

Comment on: Rebound inflammation after an intravitreal injection in Vogt–Koyanagi–Harada syndrome
por: Jain, Manish
Publicado: (2018)

Thyroid storm: Does dexmedetomidine have a role?
por: Singh, Ranju, et al.
Publicado: (2020)

The short-term effects of intravitreal aflibercept injections and dexamethasone implant on ocular hemodynamics in retinal vein occlusions
por: Ciloglu, Emine, et al.
Publicado: (2019)

Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab
por: Lee, Jong Wook, et al.
Publicado: (2016)

Short‐term effect on the ocular circulation induced by unilateral intravitreal injection of aflibercept in age‐related maculopathy
por: Mursch‐Edlmayr, Anna Sophie, et al.
Publicado: (2019)

Does ganciclovir exert retinal toxicity after multiple continuous intravitreal injections?
por: Hu, Feng, et al.
Publicado: (2021)

Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy
por: Yamada, Chizu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rlfedt4t83j9fffhv7ilg753g1